Saudi firm Najm inks accident management deal with UAE’s Saaed company

Saaed’s CEO Ibrahim Yousef Ramel (left) & Najm’s CEO Mohammad Al Suliman (right) during agreement signing in Riyadh
Updated 19 November 2019

Saudi firm Najm inks accident management deal with UAE’s Saaed company

  • Al-Suliman stressed the importance of the insurance sector as a major component of public life, a key contributor to the non-oil local economy in the Kingdom, as well as a main target for enhancing the quality of life as outlined in Saudi Vision 2030

RIYADH: Saudi traffic insurance entity Najm Insurance Services and Emirati traffic control company Saaed have signed an agreement in order to improve accident management and vehicle insurance services in Saudi Arabia and the UAE.
They signed the agreement in Riyadh on Sunday in the presence of Najm’s CEO Mohammad Al-Suliman and Saaed’s CEO Ibrahim Yousef Ramel.
Commenting on the partnership Al-Suliman said: “This agreement forms a starting point for fruitful cooperation between the two nations in the traffic systems sector.”
He added: “Saeed’s work complements Najm’s; where Najm is specialized in vehicle insurance services, Saeed possesses a solid expertise in accident management, which forms an opportunity to achieve a beneficial knowledge exchange, and result in a successful liaison that adds value to the insurance sectors of the two nations.”
Al-Suliman stressed the importance of the insurance sector as a major component of public life, a key contributor to the non-oil local economy in the Kingdom, as well as a main target for enhancing the quality of life as outlined in Saudi Vision 2030.

FASTFACT

Najm Insurance Services, a national company established in 2007 as a result of cooperation between the Saudi Arabian Monetary Authority and the General Authority of Traffic, aims to facilitate road traffic activity and support the vehicle insurance industry in the Kingdom.

“Owing to the support provided by the Saudi Monetary Authority (SAMA) and its partnership with the General Authority of Traffic, Najm is keen to develop its services, in particular the vehicle insurance sector, which forms its key mandate and the second largest insurance division in the Kingdom, with 32 percent of all insurance activity,” he told Arab News, adding that Najm had become a role model for other insurance services.
Ramel expressed his delight at signing this agreement, which reiterates the significance of integration to ensure customer satisfaction, enhance the position of both entities and raise their contribution towards achieving an improved quality of life in Saudi Arabia and the UAE.
“The cooperation between the two entities will add value and form a strong basis for a bright future and the development targets of Saudi Arabia and the UAE,” he said.


Naif Al-Harbi, head of research quality management at King Abdullah International Medical Research Center

Updated 23 September 2020

Naif Al-Harbi, head of research quality management at King Abdullah International Medical Research Center

Dr. Naif Al-Harbi is the director of vaccine development unit and head of research quality management at King Abdullah International Medical Research Center (KAIMRC).

KAIMRC recently confirmed its willingness to cooperate with the Health Ministry and the Saudi Food and Drug Authority to test vaccines that are currently in their trial phase.

Al-Harbi said that it was unprecedented to have nine vaccines in the third stage of clinical trials.

“Approval or disapproval of any drug normally follows the third stage of its clinical trials, which is the last stage,” he added. “Since the pandemic, KAIMRC has been in continuous contact with several drug companies in four countries (that are developing vaccines),” he added.

Al-Harbi obtained a bachelor’s degree in medical microbiology at Qassim University in 2006. In 2010, he completed his master’s degree in molecular medical microbiology from the University of Nottingham, UK.

He did a Ph.D. in molecular virology and vaccinology from the University of Oxford in 2014 and he pursued a fellowship in vaccinology there between 2015 and 2016.

Al-Harbi joined KAIMRC as a research technologist in 2007. His association with the center continued as an on-scholarship technologist throughout his studies.

In 2015, he became a postdoctoral researcher for almost two years, and in 2017 he joined KAIMRC’s research credentialing committee as a member, while simultaneously heading the biosafety office until March 2020.

He currently holds several positions at KAIMRC, including associate research scientist, director of the vaccine development unit (since April 2020) and head of research quality management (since March 2019).

He is also a member of numerous committees such as animal research and ethics, and research integrity and misconduct.

Al-Harbi has been a visiting fellow at the University of Oxford since January 2018. He is also co-lead in the pandemic preparedness unit at the G20 Secretariat.